Peter Hirth

机构：Continental Emitec (Germany)

发表论文 57 篇 · 总被引 9552 次 · h-index 24

代表论文

• Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma (2010 · Nature · 被引 1856)
• Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity (2008 · Proceedings of the National Academy of Sciences · 被引 1367)
• Inhibition of VEGF receptors causes lung cell apoptosis and emphysema (2000 · Journal of Clinical Investigation · 被引 1123)
• Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitors (1997 · Science · 被引 1114)
• Vemurafenib: the first drug approved for BRAF-mutant cancer (2012 · Nature Reviews Drug Discovery · 被引 842)
• Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension (2001 · The FASEB Journal · 被引 813)